← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vasarya Therapeutics, Inc.
Camden, DE
$1,759,671
Total funding
2
Grants
Funding over time
peak $1.1M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$1,759,671 · 2
By mechanism
R44$1,463,750 · 1
R41$295,921 · 1
Investigators at Vasarya Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary Fibrosis$1,107,500
R44 · FY2025 · HL
Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary Fibrosis$356,250
R44 · FY2024 · HL
Targeting a disease-specific conformation of fibronectin as a novel approach for liver fibrosis treatment$295,921
R41 · FY2024 · DK